Insight Molecular Diagnostics Inc (IMDX) Wheel Strategy

Running a IMDX wheel strategy lets you generate consistent premium income on Insight Molecular Diagnostics Inc while setting your own entry and exit prices on the underlying. Insight Molecular Diagnostics Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own IMDX, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best IMDX wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on IMDX, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable IMDX wheel from a losing one.

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system.

OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the IMDX wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your IMDX wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.